Keenan, Bridget
Tempero, Margaret
Chapter History
First Online: 25 August 2021
Compliance with Ethical Standards
:
: Not applicable.
: B. Keenan has received research grants from Partner Therapeutics. M. Tempero has received grants from Celgene and Halozyme and is an advisory board member for AbbVie, AstraZeneca, Biotech Research Group, Boehriner Ingelheim, Bristol-Myers Squibb, Corcept Therapeutics, Geistlich Pharma, Merck & Co., Seagen, Inc., Swedish Orphan Biovitrum and an consultant for ISPEN, Incyte, and Karyopharm Therapeutics.
: <b>Ethical approval</b> This article does not contain any studies with human participants performed by any of the authors.
: <b>Ethical approval</b> This article does not contain any studies with animals performed by any of the authors.
: Not applicable.